Article Information
History
- February 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Carmen Hernandez-Cardenas1,
- Ireri Thirion-Romero1,
- Norma E. Rivera-Martinez2,
- Patricia Meza-Meneses3,
- Arantxa Remigio-Luna1,
- Rogelio Perez-Padilla1,# and
- on behalf of the Research Group on hydroxychloroquine for COVID-19*
- 1Instituto Nacional de Enfermedades Respiratorias; CP 14080, Mexico City, Mexico
- 2Hospital Regional de Alta Especialidad Oaxaca; CP 71256, Oaxaca, Mexico
- 3Hospital Regional de Alta Especialidad Ixtapaluca; CP 53560, Edo de México, Mexico
- ↵#Correspondence:
Dr. Rogelio Perez Padilla, Instituto Nacional de Enfermedades Respiratorias, Mexico City., e-mail perezpad{at}gmail.com